These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 25095718)

  • 1. Selective internal radiotherapy (SIRT) versus transarterial chemoembolization (TACE) for the treatment of intrahepatic cholangiocellular carcinoma (CCC): study protocol for a randomized controlled trial.
    Kloeckner R; Ruckes C; Kronfeld K; Wörns MA; Weinmann A; Galle PR; Lang H; Otto G; Eichhorn W; Schreckenberger M; Dueber C; Pitton MB
    Trials; 2014 Aug; 15():311. PubMed ID: 25095718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.
    Seidensticker R; Ricke J; Seidensticker M
    Best Pract Res Clin Gastroenterol; 2015 Apr; 29(2):319-32. PubMed ID: 25966431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transarterial radioembolization versus chemoembolization for the treatment of hepatocellular carcinoma (TRACE): study protocol for a randomized controlled trial.
    Seinstra BA; Defreyne L; Lambert B; Lam MG; Verkooijen HM; van Erpecum KJ; van Hoek B; van Erkel AR; Coenraad MJ; Al Younis I; van Vlierberghe H; van den Bosch MA
    Trials; 2012 Aug; 13():144. PubMed ID: 22913492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Degradable Starch Microspheres Transcatheter Arterial Chemoembolization (DSM-TACE) in Intrahepatic Cholangiocellular Carcinoma (ICC): Results from a National Multi-Center Study on Safety and Efficacy.
    Schicho A; Pereira PL; Pützler M; Michalik K; Albrecht T; Nolte-Ernsting C; Stroszczynski C; Wiggermann P
    Med Sci Monit; 2017 Feb; 23():796-800. PubMed ID: 28192388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
    Mumdzhiev N; Borisov B; Tenev R; Radicheva M
    Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
    Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
    BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-disciplinary treatment for cholangiocellular carcinoma.
    Shimoda M; Kubota K
    World J Gastroenterol; 2007 Mar; 13(10):1500-4. PubMed ID: 17461440
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Unresectable combined hepatocellular-cholangiocellular carcinoma treated with transcatheter arterial chemoembolization and gemcitabine: a case study].
    Sano T; Ishikawa T; Imai M; Owaki T; Sato H; Nozawa Y; Iwanaga A; Seki K; Honma T; Yoshida T; Nishikura K; Ishihara N; Kamimura T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(12):1069-1077. PubMed ID: 30531113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
    Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R
    Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transarterial radioembolization of hepatocellular carcinoma and intrahepatic cholangiocarcinoma].
    Helmberger T; Pereira PL
    Radiologe; 2022 Mar; 62(3):234-238. PubMed ID: 35171313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial chemoembolization (TACE) for inoperable intrahepatic cholangiocarcinoma.
    Herber S; Otto G; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann A; Thies J; Düber C; Pitton M
    Cardiovasc Intervent Radiol; 2007; 30(6):1156-65. PubMed ID: 17508242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of postoperative adjuvant transarterial chemoembolization on the prognosis of early-stage intrahepatic cholangiocarcinoma: a single center study.
    Liu G; Guo W; Wang H; Liu W; Lei L; Xie Q; Li X; Zou S; Wang P; Zhou H; Hu H
    Ann Palliat Med; 2021 Apr; 10(4):3673-3683. PubMed ID: 33691434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Regional therapy of liver tumors].
    Spangenberg HC; Mohr L; Blum HE
    Internist (Berl); 2007 Jan; 48(1):40-5. PubMed ID: 17160664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemoembolization with Degradable Starch Microspheres for Treatment of Patients with Primary or Recurrent Unresectable, Locally Advanced Intrahepatic Cholangiocarcinoma: A Pilot Study.
    Goerg F; Zimmermann M; Bruners P; Neumann U; Luedde T; Kuhl C
    Cardiovasc Intervent Radiol; 2019 Dec; 42(12):1709-1717. PubMed ID: 31578633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrahepatic cholangiocarcinoma - current perspectives and treatment algorithm].
    Lurje G; Bednarsch J; Roderburg C; Trautwein C; Neumann UP
    Chirurg; 2018 Nov; 89(11):858-864. PubMed ID: 30182267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization versus percutaneous microwave coagulation therapy for recurrent unresectable intrahepatic cholangiocarcinoma: Development of a prognostic nomogram.
    Ge Y; Jeong S; Luo GJ; Ren YB; Zhang BH; Zhang YJ; Shen F; Cheng QB; Sui CJ; Wang HY; Xia Q; Chen L
    Hepatobiliary Pancreat Dis Int; 2020 Apr; 19(2):138-146. PubMed ID: 32139295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsurgical therapies for hepatocellular and cholangiocellular carcinoma.
    Schmassmann A
    Swiss Surg; 1999; 5(3):116-21. PubMed ID: 10414182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of surgical resection of a combined hepatocellular and cholangiocarcinoma after transarterial chemoembolization].
    Yakoshi Y; Toyoki Y; Ishido K; Kudo D; Kimura N; Wakiya T; Hakamada K
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1798-800. PubMed ID: 24393926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.
    Eltawil KM; Berry R; Abdolell M; Molinari M
    HPB (Oxford); 2012 May; 14(5):341-50. PubMed ID: 22487072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma.
    Park SY; Kim JH; Yoon HJ; Lee IS; Yoon HK; Kim KP
    Clin Radiol; 2011 Apr; 66(4):322-8. PubMed ID: 21356394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.